11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2014
-
Mark
Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype
(
- Contribution to journal › Article
-
Mark
Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy
(
- Contribution to journal › Article
- 2013
-
Mark
Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma
(
- Contribution to journal › Article
- 2012
-
Mark
Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma
(
- Contribution to journal › Article
- 2011
-
Mark
Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC)
(
- Contribution to journal › Article
- 2010
-
Mark
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
(
- Contribution to journal › Article
- 2009
-
Mark
Highly increased familial risks for specific lymphoma subtypes
(
- Contribution to journal › Article
- 2007
-
Mark
Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis
(
- Contribution to journal › Article
- 2003
-
Mark
Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »